IRIS
MAFFEZZOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.228
NA - Nord America 1.057
EU - Europa 511
SA - Sud America 176
AF - Africa 70
OC - Oceania 4
Totale 3.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.016
SG - Singapore 412
IT - Italia 227
VN - Vietnam 223
CN - Cina 200
BD - Bangladesh 171
BR - Brasile 142
HK - Hong Kong 85
FR - Francia 58
DE - Germania 47
ZA - Sudafrica 42
NL - Olanda 37
GB - Regno Unito 35
IN - India 32
IE - Irlanda 24
CA - Canada 21
RU - Federazione Russa 19
AR - Argentina 17
IQ - Iraq 14
KR - Corea 14
JP - Giappone 12
AT - Austria 11
SE - Svezia 11
MA - Marocco 10
MX - Messico 10
FI - Finlandia 8
PH - Filippine 8
TR - Turchia 8
UZ - Uzbekistan 8
ES - Italia 7
MY - Malesia 7
TH - Thailandia 7
CO - Colombia 6
ID - Indonesia 6
PK - Pakistan 6
PL - Polonia 6
EC - Ecuador 5
EG - Egitto 5
KE - Kenya 5
AU - Australia 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CI - Costa d'Avorio 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
PE - Perù 2
SA - Arabia Saudita 2
UA - Ucraina 2
BB - Barbados 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 3.046
Salva come PNG Salva come JPEG
Città #
Singapore 265
Ashburn 183
Dallas 174
San Jose 142
Hong Kong 82
Santa Clara 81
Ho Chi Minh City 69
Boardman 59
Beijing 49
Hanoi 42
Johannesburg 39
Hefei 35
Los Angeles 33
New York 33
Milan 29
Munich 25
Dublin 24
Buffalo 23
Lauterbourg 22
Parma 19
Marseille 16
Modena 16
São Paulo 14
Shanghai 13
Da Nang 12
Brooklyn 11
Seoul 11
Orem 10
Bologna 9
Chennai 9
Council Bluffs 9
Haiphong 9
Moscow 9
Paris 9
Tokyo 9
Bengaluru 8
Chicago 8
Rome 8
Atlanta 7
Denver 7
Houston 7
London 7
Montreal 7
Nuremberg 7
Portsmouth 7
Rio de Janeiro 7
Tashkent 7
Amsterdam 6
Columbus 6
Frankfurt am Main 6
Meknes 6
Poplar 6
Seattle 6
Turku 6
Venice 6
Vienna 6
Baghdad 5
Bangkok 5
Quito 5
Stockholm 5
Curitiba 4
Nairobi 4
Ninh Bình 4
Sungai Petani 4
Warsaw 4
Aachen 3
Abidjan 3
Ancona 3
Bari 3
Bauru 3
Belo Horizonte 3
Biên Hòa 3
Boston 3
Brescia 3
Buenos Aires 3
Cape Town 3
Düsseldorf 3
Genoa 3
Lahore 3
Ottawa 3
Paderno Dugnano 3
Perugia 3
Phoenix 3
Poços de Caldas 3
Salt Lake City 3
Scandiano 3
Thái Nguyên 3
Tianjin 3
Athens 2
Baku 2
Brasília 2
Brussels 2
Busto Arsizio 2
Bắc Ninh 2
Cairo 2
Can Tho 2
Caxias do Sul 2
Chandigarh 2
Chengdu 2
Cologno Monzese 2
Totale 1.868
Salva come PNG Salva come JPEG
Nome #
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review 178
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 167
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 154
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 151
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 148
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 137
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 135
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 130
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 124
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations 116
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 115
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 115
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 114
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. 114
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 113
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 106
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental Survey 100
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 93
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 92
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 91
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review 86
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 83
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 81
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 74
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? 72
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 68
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review 60
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort 47
A prospective external validation of the GRade, Age, Nodes and Tumor score in the ECOG-ACRIN EA8143 PROSPER trial 6
When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma 4
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study 3
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma 2
Totale 3.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025648 7 36 44 35 69 69 38 49 55 57 59 130
2025/20262.249 154 156 328 199 249 136 160 91 242 151 244 139
Totale 3.079